Cargando…

Defining benefit threshold for extracorporeal membrane oxygenation in children with sepsis—a binational multicenter cohort study

BACKGROUND: The surviving sepsis campaign recommends consideration for extracorporeal membrane oxygenation (ECMO) in refractory septic shock. We aimed to define the benefit threshold of ECMO in pediatric septic shock. METHODS: Retrospective binational multicenter cohort study of all ICUs contributin...

Descripción completa

Detalles Bibliográficos
Autores principales: Schlapbach, Luregn J., Chiletti, Roberto, Straney, Lahn, Festa, Marino, Alexander, Daniel, Butt, Warwick, MacLaren, Graeme
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6937937/
https://www.ncbi.nlm.nih.gov/pubmed/31888705
http://dx.doi.org/10.1186/s13054-019-2685-1
_version_ 1783483970920382464
author Schlapbach, Luregn J.
Chiletti, Roberto
Straney, Lahn
Festa, Marino
Alexander, Daniel
Butt, Warwick
MacLaren, Graeme
author_facet Schlapbach, Luregn J.
Chiletti, Roberto
Straney, Lahn
Festa, Marino
Alexander, Daniel
Butt, Warwick
MacLaren, Graeme
author_sort Schlapbach, Luregn J.
collection PubMed
description BACKGROUND: The surviving sepsis campaign recommends consideration for extracorporeal membrane oxygenation (ECMO) in refractory septic shock. We aimed to define the benefit threshold of ECMO in pediatric septic shock. METHODS: Retrospective binational multicenter cohort study of all ICUs contributing to the Australian and New Zealand Paediatric Intensive Care Registry. We included patients < 16 years admitted to ICU with sepsis and septic shock between 2002 and 2016. Sepsis-specific risk-adjusted models to establish ECMO benefit thresholds with mortality as the primary outcome were performed. Models were based on clinical variables available early after admission to ICU. Multivariate analyses were performed to identify predictors of survival in children treated with ECMO. RESULTS: Five thousand sixty-two children with sepsis and septic shock met eligibility criteria, of which 80 (1.6%) were treated with veno-arterial ECMO. A model based on 12 clinical variables predicted mortality with an AUROC of 0.879 (95% CI 0.864–0.895). The benefit threshold was calculated as 47.1% predicted risk of mortality. The observed mortality for children treated with ECMO below the threshold was 41.8% (23 deaths), compared to a predicted mortality of 30.0% as per the baseline model (16.5 deaths; standardized mortality rate 1.40, 95% CI 0.89–2.09). Among patients above the benefit threshold, the observed mortality was 52.0% (13 deaths) compared to 68.2% as per the baseline model (16.5 deaths; standardized mortality rate 0.61, 95% CI 0.39–0.92). Multivariable analyses identified lower lactate, the absence of cardiac arrest prior to ECMO, and the central cannulation (OR 0.31, 95% CI 0.10–0.98, p = 0.046) as significant predictors of survival for those treated with VA-ECMO. CONCLUSIONS: This binational study demonstrates that a rapidly available sepsis mortality prediction model can define thresholds for survival benefit in children with septic shock considered for ECMO. Survival on ECMO was associated with central cannulation. Our findings suggest that a fully powered RCT on ECMO in sepsis is unlikely to be feasible.
format Online
Article
Text
id pubmed-6937937
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-69379372019-12-31 Defining benefit threshold for extracorporeal membrane oxygenation in children with sepsis—a binational multicenter cohort study Schlapbach, Luregn J. Chiletti, Roberto Straney, Lahn Festa, Marino Alexander, Daniel Butt, Warwick MacLaren, Graeme Crit Care Research BACKGROUND: The surviving sepsis campaign recommends consideration for extracorporeal membrane oxygenation (ECMO) in refractory septic shock. We aimed to define the benefit threshold of ECMO in pediatric septic shock. METHODS: Retrospective binational multicenter cohort study of all ICUs contributing to the Australian and New Zealand Paediatric Intensive Care Registry. We included patients < 16 years admitted to ICU with sepsis and septic shock between 2002 and 2016. Sepsis-specific risk-adjusted models to establish ECMO benefit thresholds with mortality as the primary outcome were performed. Models were based on clinical variables available early after admission to ICU. Multivariate analyses were performed to identify predictors of survival in children treated with ECMO. RESULTS: Five thousand sixty-two children with sepsis and septic shock met eligibility criteria, of which 80 (1.6%) were treated with veno-arterial ECMO. A model based on 12 clinical variables predicted mortality with an AUROC of 0.879 (95% CI 0.864–0.895). The benefit threshold was calculated as 47.1% predicted risk of mortality. The observed mortality for children treated with ECMO below the threshold was 41.8% (23 deaths), compared to a predicted mortality of 30.0% as per the baseline model (16.5 deaths; standardized mortality rate 1.40, 95% CI 0.89–2.09). Among patients above the benefit threshold, the observed mortality was 52.0% (13 deaths) compared to 68.2% as per the baseline model (16.5 deaths; standardized mortality rate 0.61, 95% CI 0.39–0.92). Multivariable analyses identified lower lactate, the absence of cardiac arrest prior to ECMO, and the central cannulation (OR 0.31, 95% CI 0.10–0.98, p = 0.046) as significant predictors of survival for those treated with VA-ECMO. CONCLUSIONS: This binational study demonstrates that a rapidly available sepsis mortality prediction model can define thresholds for survival benefit in children with septic shock considered for ECMO. Survival on ECMO was associated with central cannulation. Our findings suggest that a fully powered RCT on ECMO in sepsis is unlikely to be feasible. BioMed Central 2019-12-30 /pmc/articles/PMC6937937/ /pubmed/31888705 http://dx.doi.org/10.1186/s13054-019-2685-1 Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Schlapbach, Luregn J.
Chiletti, Roberto
Straney, Lahn
Festa, Marino
Alexander, Daniel
Butt, Warwick
MacLaren, Graeme
Defining benefit threshold for extracorporeal membrane oxygenation in children with sepsis—a binational multicenter cohort study
title Defining benefit threshold for extracorporeal membrane oxygenation in children with sepsis—a binational multicenter cohort study
title_full Defining benefit threshold for extracorporeal membrane oxygenation in children with sepsis—a binational multicenter cohort study
title_fullStr Defining benefit threshold for extracorporeal membrane oxygenation in children with sepsis—a binational multicenter cohort study
title_full_unstemmed Defining benefit threshold for extracorporeal membrane oxygenation in children with sepsis—a binational multicenter cohort study
title_short Defining benefit threshold for extracorporeal membrane oxygenation in children with sepsis—a binational multicenter cohort study
title_sort defining benefit threshold for extracorporeal membrane oxygenation in children with sepsis—a binational multicenter cohort study
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6937937/
https://www.ncbi.nlm.nih.gov/pubmed/31888705
http://dx.doi.org/10.1186/s13054-019-2685-1
work_keys_str_mv AT schlapbachluregnj definingbenefitthresholdforextracorporealmembraneoxygenationinchildrenwithsepsisabinationalmulticentercohortstudy
AT chilettiroberto definingbenefitthresholdforextracorporealmembraneoxygenationinchildrenwithsepsisabinationalmulticentercohortstudy
AT straneylahn definingbenefitthresholdforextracorporealmembraneoxygenationinchildrenwithsepsisabinationalmulticentercohortstudy
AT festamarino definingbenefitthresholdforextracorporealmembraneoxygenationinchildrenwithsepsisabinationalmulticentercohortstudy
AT alexanderdaniel definingbenefitthresholdforextracorporealmembraneoxygenationinchildrenwithsepsisabinationalmulticentercohortstudy
AT buttwarwick definingbenefitthresholdforextracorporealmembraneoxygenationinchildrenwithsepsisabinationalmulticentercohortstudy
AT maclarengraeme definingbenefitthresholdforextracorporealmembraneoxygenationinchildrenwithsepsisabinationalmulticentercohortstudy
AT definingbenefitthresholdforextracorporealmembraneoxygenationinchildrenwithsepsisabinationalmulticentercohortstudy